Analysis for BG
- 📈 Growth — 24/30
- 💰 Profitability — 16/20
- 🏦 Financial Health — 18/20
- 💵 Valuation — 14/20
- ⚠️ Risk — 6/10
Summary:
📈 Growth & Financial Trajectory
Over the 8 quarters, revenues rise from about $13.54B in 2024 Q4 to about $24.04B in 2026 Q2, a substantial expansion. Net income moves from roughly $0.63B to about $0.71B, but the path shows volatility (notable dips in mid-2025 followed by a late‑2025 surge). Overall, a positive top‑line trajectory with a modest net‑income uptick.
💰 Margins & Cash Flow
Gross margins hover in the mid‑single digits, roughly 5–8%, with occasional pressure near 4% and peaks near 7–8%. Operating margins remain slim, often under 5%. Cash flow from operations is mixed: several quarters show positive CFO (late 2024 and late 2025), but multiple periods run negative, reflecting working‑capital and seasonal/commodity cycle effects; investing/financing flows amplify cash variability.
🛡️ Balance Sheet & Liquidity
Balance sheet remains solid: assets around $46.8B and liabilities about $29.4B, yielding equity near $17.3B–$18.0B. Long‑term debt runs around $10.6B. Current assets ($26.2B) comfortably cover current liabilities ($16.7B), implying a healthy current ratio (~1.57) and structural resilience to cycle swings.
⚠️ Key Drivers & Risks
- Drivers: Global agricultural commodity demand; robust logistics/processing footprint.
- Risks: Commodity price cyclicality and margin compression; pronounced cash flow volatility and potential valuation sensitivity.